Problems viewing this newsletter? View it in your browser >

What's New at

August 13, 2015

Dear Advocate,

AVAC’s website has lots to explore and is constantly updated. If you haven’t visited recently, here’s a small sample of what you’ve missed:

#TargetsMatter — Devex recently published Right things, right places, right targets — right now, an article calling on the US President's Emergency Plan for AIDS Relief (PEPFAR) to set new treatment and prevention targets. Find key quotes, a link to the full piece and AVAC and partners’ argument about why the time for new PEPFAR targets is now. 

HIV Prevention Research & Development Funding Trends, 2000-2014 — Since 2004, this annual report has tracked trends and identified investment gaps in HIV prevention research. In 2014 HIV prevention R&D decreased by US$10 million from the previous year.
IAS 2015 Roundup — Read a series of blog posts with our “take” on key conference events and new data presented. Slides and audio from our post-conference webinar, What was presented and what it means on the road to Durban 2016, are also available.

US National HIV/AIDS Strategy Gets a Reboot — A prevention advocate's take on the new "NHAS". Updated on its fifth anniversary, the new US National HIV/AIDS Strategy has renewed focus on evidence-based interventions, scaling up testing and tracking incidence, as well as a new emphasis on PrEP.

Oral Pre-Exposure Prophylaxis: Putting a new choice in context — A joint collaboration of UNAIDS, WHO and AVAC, this publication is intended to complement expected, forthcoming WHO recommendations and support the optimal use of oral PrEP.

Newly Updated Infographic — Appearing first in AVAC Report 2014/15: HIV Prevention on the Line, this recently updated graphic shows planned, ongoing and completed PrEP evaluation studies.

Have a comment on one of our blog posts? Is there an infographic we should feature? We’d love to hear from you at


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423